Table 1. Table 1. Composition of Formulations Tested

Twenty healthy volunteers ages 35—65 with mixed skin types were enrolled in a trial where a single-blind, split-face, randomized protocol was used to evaluate the efficacy of a placebo formulation against a formulation containing 3% S. longicruris (see Table 1).